COVID-19 Active Research Experience (CARE) is an observational, direct-to-participant, web-based, longitudinal study of adults with COVID-19 or COVID-19 like illness or who were vaccinated against COVID-19 to better understand risk factors, symptoms, and treatments for COVID-19 illness and vaccine safety and effectiveness.
This is an observational, direct-to-participant, web-based, longitudinal study of adults with
COVID-19 or COVID-19 like illness to better understand risk factors, symptoms, and treatments
for COVID-19 illness and vaccine safety and effectiveness. Upon consent and enrollment,
participants will complete an initial baseline survey reporting their demographics, relevant
medical history, testing, vaccination, symptoms, use of prescription medications as well as
use of supplements and other factors. The study follow-up period is 12 months. During the
first month of follow-up participants will be invited to complete a symptom diary weekly to
gauge symptom progression and severity and to provide updates on pharmaceutical and
non-pharmaceutical interventions as well as healthcare encounters. Reporting will then reduce
to monthly for Month 2 through 12.
Inclusion Criteria:
- Adult (18 years or older)
- Currently living in the US or UK
- Have regular access to a computer, smartphone or tablet and sufficient internet to
support registry demands (note: this registry is designed to operate well even in
regions with low bandwidth)
- Willing and able to provide informed consent
- Willing and able to follow the procedures of the study
Participants must also meet at least one of the following conditions:
- Have COVID-19 or COVID-19 like symptoms
- Received a COVID-19 vaccine
- Potential exposure to COVID-19
Exclusion Criteria:
- Unable to provide informed consent
- Unable to perform the requested study tasks and unable or unwilling to assign a proxy
informant to complete the tasks
IQVIA
Cambridge, Massachusetts, United States
IQVIA
London, United Kingdom
Nancy Dreyer, PhD, MPH, Principal Investigator
Iqvia Pty Ltd